Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Clinical trial NCT03490292 · COMPLETED
Trial details
- NCT number
- NCT03490292
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2022-01-19
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.